From Unlisted to Listed: The Big Pre-IPO Names Going Public in 2026 (NSE Files Its DRHP)
NSE filed its DRHP with SEBI on 17 June 2026. A factual look at the pre-IPO pipeline, what 'DRHP filed' vs 'SEBI approved' means, and what it changes for unlisted holders.
Reviewed by Team BuyUnlistedShares Research Desk
From Unlisted to Listed: The Big Pre-IPO Names Going Public in 2026 (NSE Files Its DRHP)
Reviewed by Team BuyUnlistedShares Research Desk Last Updated: July 2026
The move from the unlisted market to a public listing is the single most significant event in an unlisted share’s life, and 2026 has put one of the biggest names on that path. The National Stock Exchange (NSE) filed its Draft Red Herring Prospectus (DRHP) with SEBI on 17 June 2026. For a company that has been among the most actively traded names in the unlisted market for years, this is a milestone worth understanding carefully.
This article explains, on the facts, what NSE’s DRHP filing means, sketches the wider pre-IPO pipeline that is drawing attention, and clarifies the difference between “DRHP filed” and “SEBI approved”. It gives no price target and no view on whether any unlisted name is worth buying.
What NSE’s DRHP Filing Actually Says
According to the draft filing, NSE’s proposed IPO is structured as an Offer for Sale (OFS) of roughly 6% of the company, amounting to up to 14.89 crore shares being offered by existing shareholders. Because it is an OFS, the shares are being sold by current holders and the proceeds go to them, not to the exchange as fresh capital.
In the unlisted market, NSE shares have been quoted in a range of approximately ₹1,950 to ₹2,050. It is important to read that number for what it is. Unlisted prices are indicative and illiquid — they reflect a small volume of private transactions, are not set on a regulated exchange, and can move sharply or be hard to transact at the quoted level. They are a reference point, not a market price in the exchange-traded sense.
For a deeper breakdown of the filing itself, see our dedicated note on the NSE DRHP filing of June 2026.
The Wider Pre-IPO Pipeline
NSE is the marquee name, but it sits within a much larger queue. Market commentary places the broader pre-IPO pipeline of unlisted and privately held companies in the region of ₹1.75 to ₹1.80 lakh crore of potential offerings working their way toward the public market. Alongside NSE, other well-known unlisted names have featured in the news queue, including:
- Reliance Jio (Jio Platforms) — one of the most watched names in the pre-IPO conversation, discussed in our Reliance Jio Platforms profile.
- Manipal Health Enterprises — a large hospital group whose unlisted shares are widely tracked, covered in our Manipal Hospitals unlisted share note.
These names appear here because they are part of the publicly reported pipeline, not as picks. Whether, when, and at what price any of them lists depends on their own filings, regulatory timelines, and market conditions. This article attaches no valuation or target to any of them.
“DRHP Filed” Is Not “SEBI Approved”
A common misunderstanding is to treat a DRHP filing as if the IPO were imminent or approved. It is not. The two are distinct stages in a regulated sequence.
| Stage | What it means |
|---|---|
| DRHP filed | The company has submitted a draft offer document to SEBI. This is the start of the review, not the end. The document is public and open to comment. |
| SEBI observations / approval | SEBI reviews the draft and issues observations. The company must address them before proceeding. Only after this can it move toward the actual offer. |
| RHP filed | A Red Herring Prospectus with the price band and final details is filed closer to the offer. |
| Issue opens | The IPO opens for subscription on the exchanges. |
The gap between a DRHP filing and an actual listing can be several months, and a filing does not guarantee that the IPO will happen, or happen on any particular timeline. To follow the full document chain from draft to prospectus, see our explainer on DRHP vs RHP vs prospectus.
What a DRHP Filing Changes for an Unlisted Holder
If you hold shares of a company that has just filed its DRHP, several practical things shift. None of them is a reason to act in any particular direction — they are simply the mechanics you should understand.
1. A path to liquidity
The unlisted market is thin. Once a company lists, its shares trade continuously on the exchanges, which is a fundamentally more liquid environment than private transfers. A DRHP filing is the first formal step toward that liquidity.
2. Lock-ins may apply
Pre-IPO and unlisted shareholders are frequently subject to a lock-in period after listing, during which their shares cannot be freely sold. The exact lock-in depends on the category of shareholder and the rules that apply to the issue, and it is spelled out in the offer documents. A share you hold today may not be sellable on day one of listing.
3. Price discovery moves to the exchange
Today, an unlisted price is an indicative quote from a small private market. After listing, price is set continuously by public buyers and sellers. The listed price can be higher or lower than the last unlisted quote, and the relationship between the two is not fixed or predictable.
4. OFS versus fresh issue matters
As with NSE, whether an IPO is an OFS or a fresh issue tells you where the money goes. In an OFS, existing holders sell and the company raises nothing new. In a fresh issue, new shares are created and capital flows into the company. Many IPOs combine both. This distinction affects dilution and how you read the offer.
For the broader mechanics of holding and transacting private shares before a listing, our guide on how to invest in pre-IPO shares covers the ground-level process.
Frequently Asked Questions
Q: What did NSE file, and when? A: NSE filed its Draft Red Herring Prospectus (DRHP) with SEBI on 17 June 2026. Per the draft, the proposed issue is an Offer for Sale of around 6% of the company, up to 14.89 crore shares sold by existing shareholders.
Q: Does a DRHP filing mean the IPO is approved? A: No. A DRHP filing begins SEBI’s review. The company must address SEBI’s observations before it can proceed, and the eventual listing can be months away or may not occur on any fixed timeline.
Q: Are the unlisted prices quoted for these names reliable? A: They are indicative and illiquid. Unlisted quotes reflect small private transactions, are not set on a regulated exchange, and may be difficult to transact at the stated level. Treat them as reference points from public sources, not exchange prices.
Q: What happens to my unlisted shares when the company lists? A: They may become exchange-traded, subject to any applicable lock-in period. The listed price is discovered on the exchange and can differ from the last unlisted quote in either direction.
What This Guide Is NOT
This is market news and education. It is not a recommendation to buy, sell, hold, or avoid NSE or any other unlisted name mentioned. It sets no price target and offers no valuation view on any company. Figures such as the OFS size, share count, and price ranges are attributed to the DRHP and public reporting, and unlisted prices are explicitly indicative and illiquid. Confirm all details against the official filings and consult a SEBI-registered adviser before acting.
Conclusion
NSE’s DRHP filing on 17 June 2026 is a landmark step in the unlisted-to-listed journey, and it sits inside a pre-IPO pipeline reported to run to roughly ₹1.75–1.80 lakh crore. The key discipline is to separate a filing from an approval, to read unlisted prices as indicative rather than firm, and to understand how lock-ins and the OFS-versus-fresh-issue split change the picture for a holder.
To go deeper, read our focused note on the NSE DRHP filing and the document-chain explainer on DRHP vs RHP vs prospectus.
This article was reviewed by Team BuyUnlistedShares Research Desk. The desk is NOT a SEBI-registered Research Analyst or Investment Adviser. Nothing in this article constitutes investment advice or a recommendation to buy, sell, hold, or avoid any security. Investments in unlisted securities carry significant liquidity, regulatory, and listing-timing risks. Consult a SEBI-registered Investment Adviser for personalized financial planning.
